Thompson Street Capital Partners Announces the Sale of Pulse Veterinary Technologies, LLC to Branford Castle Partners
ST. LOUIS (September 6, 2019) – Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, announced today that they have completed the sale of Pulse Veterinary Technologies, LLC (PulseVet) to New York City-based private equity firm Branford Castle Partners. Headquartered in Alpharetta, GA, PulseVet is the leading provider of extracorporeal shockwave therapy (ESWT) equipment for the minimally-invasive treatment of joint and soft tissue disorders in veterinary patients. TSCP was advised through the sale by MHT Partners. Terms of the transaction were not disclosed.
The products represent a technology platform unrivaled in terms of established efficacy, reputation and the ability to treat a broad range of musculoskeletal issues. PulseVet is focused on providing only clinically tested and proven solutions to discerning veterinarians. With a reputation as the authority on veterinary shock wave, PulseVet understands the importance of bringing only the best products and services to the industry. PulseVet serves thousands of veterinarians across more than 25 countries globally.
According to Vince Warrick, TSCP Managing Director, “Throughout our partnership with PulseVet, we accelerated revenue growth and executed on a number of strategic initiatives together. We have been pleased to work with an extremely dedicated team and believe the Company is well positioned for continued growth as the market-leading provider of extracorporeal shockwave therapy devices.”